Peer Review History

Original SubmissionDecember 14, 2022
Decision Letter - Diana Marcela Walteros Acero, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

PONE-D-22-34111STRESS SYMPTOMS AND POSITIVE COPING DURING CORONAVIRUS DISEASE 2019: THE NEED TO LOOK AT HEALTH FROM A GENDER PERSPECTIVEPLOS ONE

Dear Dr. Romo-González,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript presents a description of the methodology, the instruments used and the strategies for data collection, however, the recruitment of people who accepted a Covid-19 test is the only selection criteria.

The context of the pandemic in that locality during the study period and the conditions related to the infection that could support the conclusions, for example, severity, disability, are unknown. The conclusions must consider the factors related to the infection and not only the comorbidities and it would be interesting to see if the disease had an effect on coping.

The network analysis was done taking into account the scores of the subscales, however it is not clear how these aspects determine health and well-being with a gender perspective. It could be useful to do the network analysis with demographic variables and comorbidities

There is no description of biases or how to control them

In the introduction, the gender perspective is blurred from the pandemic and the specific situation related to acute respiratory infection by SARS-CoV-2, it is raised from health in general, which makes it difficult to understand the working hypothesis.

It remains to describe the municipality and the covid situation in the area at the project development site, which are contextual elements that can contribute to the analysis and generation of conclusions

The variables that are going to be used to analyze the gender perspective are not described, there is only sex. It is not clear if the PCWLS scale was validated in the sample studied.

Among the results, they affirm that differences were found in risk factors for contracting covid, it must be taken into account that this type of study does not allow us to rigorously identify these differences in risk factors, what is proposed is the analysis of the comorbidities of the people positive for Covid-19

It remains to be clarified whether it was possible to identify the analysis of the aspects that determine health and well-being from a gender perspective in the methods and present it in the conclusions in people with confirmed Covid-19

The selection bias that occurs when selecting people who consult a health service for symptoms of Covid-19 must be declared, since they may have different conditions or characteristics from those who do not consult.

Please take into account the reviewer's comments and consider the information provided to complement the conclusions

Please submit your revised manuscript by Apr 30 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Diana Marcela Walteros Acero, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"This research has been funded by Dirección General de Investigaciones of Universidad Santiago de Cali under call No. 01-2022."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"This research has been funded by Dirección General de Investigaciones of Universidad Santiago de Cali under call No. 01-2022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I recommend the authors to mention the following findings related to gender, COVID-19 and mental health in the Introduction and discussion, I will review this paper again.

Search PubMed for: Female gender, student status, specific physical symptoms (e.g., myalgia, dizziness, coryza), and poor self-rated health status were significantly associated with a greater psychological impact of the outbreak and higher levels of stress, anxiety, and depression (p < 0.05)

Search PubMed for: After adjusting for age, gender and comorbidities, it was found that depression (OR 2.79, 95% CI 1.54-5.07, p = 0.001), anxiety (OR 2.18, 95% CI 1.36-3.48, p = 0.001), stress (OR 3.06, 95% CI 1.27-7.41, p = 0.13), and PTSD (OR 2.20, 95% CI 1.12-4.35, p = 0.023) remained significantly associated with the presence of physical symptoms experienced in the preceding month.

Search PubMed for: Risk factors associated with distress measures include female gender, younger age group (≤40 years), presence of chronic/psychiatric illnesses, unemployment, student status, and frequent exposure to social media/news concerning COVID-19.

Search PubMed for: Female gender; youth age; single status; students; specific symptoms; recent imposed quarantine; prolonged home-stay; and reports of poor health status, unnecessary worry, concerns for family members, and discrimination were significantly associated with greater psychological impact of the pandemic and higher levels of stress, anxiety and depression (p<0.05).

Search PubMed for: Comprehensive strategies for the screen of psychological problems and to support high-risk groups are critical, especially females, middle-aged adults and the elderly, affected laborers, and health care professionals.

Search PubMed for: Being female, having chronic conditions and living in the family with 3-5 members were associated with lower HRQOL scores. A comprehensive assessment of the influence of COVID-19 along with public health interventions, especially mental health programs

Search PubMed for: Higher awareness of local pandemic situation was associated with female respondents (Coef.: 6.19; 95% CI: 0.51; 11.87) and larger family sizes of above 5 people (Coef.: 9.00; -1.00; 19.00). Respondents between 35-44 years old were shown to be less aware of preventive behavioral practices than other age groups, including the group of participants above 44 years old (Coef.: -0.34; 95% CI: -0.67; -0.02).

Search PubMed for: Seventy pregnant women (8.1%) reported that their antenatal care was influenced by the COVID-19. In this group, a higher level of satisfaction with the care of parents-in-law

Search PubMed for: Of 651 pregnant women, 60.4% accepted to receive the vaccine, and 82.6% of the total pregnant women were willing to pay for a COVID-19 vaccine with the mean amount of WTP of USD 15.2 (SD ± 27.4).

Search PubMed for: The subgroups identified to have a higher risk of psychiatric symptoms among the general public include females, the elderly, individuals with chronic illness, migrant workers, and students.

Please discuss the role of female gender based on the following papers.

Investigating Psychological Differences Between Nurses and Other Health Care Workers From the Asia-Pacific Region During the Early Phase of COVID-19: Machine Learning Approach. JMIR Nurs. 2022 Jun 1;5(1):e32647. doi: 10.2196/32647. PMID: 35648464; PMCID: PMC9162133.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Diana Marcela Walteros Acero, M.D.

Academic Editor

PLOS ONE

Regarding the manuscript entitled " Stress symptoms and positive coping during coronavirus disease 2019: the need to look at health from a gender perspective, that we submitted to the PLOS ONE, I take this opportunity to thank the reviewers for their comments and suggestions.

Comments from the Editor:

The context of the pandemic in that locality during the study period and the conditions related to the infection that could support the conclusions, for example, severity, disability, are unknown. The conclusions must consider the factors related to the infection and not only the comorbidities and it would be interesting to see if the disease had an effect on coping.

R= We explain the context of the epidemic in the state of Veracruz in the following text:

In the case of the state of Veracruz, diabetes occurs as the 2nd. most prevalent disease, and cardiovascular diseases are the second cause of death (27-28), and the city of Veracruz, were the data were collected, was the city with more Covid-19 reported cases.

The city of Veracruz was one of the cities with the highest number of cases during the first months after the declaration of a pandemic by COVID-19 and it remained at a red epidemiological light for longer than most of the municipalities in the state of Veracruz. It is important to point out that the city of Veracruz also had a greater number of hospitals with diagnostic capacity for SARS CoV-2, but given that the number of confirmed cases was always high, the population that had the possibility of performing the diagnostic test in another site, looked for alternatives, such as going to the CESS, hence our sampling was not random, but for convenience.

2. The network analysis was done taking into account the scores of the subscales, however it I s not clear how these aspects determine health and well-being with a gender perspective. It could be useful to do the network analysis with demographic variables and comorbidities. There is no description of biases or how to control them.

R=Although the network analysis considers the factors that make up the two subscales of the positive coping instrument separately, the factors show more clearly how participants can cope with difficult situations, or fully enjoy positive situations.

3. In the introduction, the gender perspective is blurred from the pandemic and the specific situation related to acute respiratory infection by SARS-CoV-2, it is raised from health in general, which makes it difficult to understand the working hypothesis.

R=We have reduced the text that refers to the pandemic, so as not to divert attention from the gender perspective and how it should be considered in health.

4. It remains to describe the municipality and the covid situation in the area at the project development site, which are contextual elements that can contribute to the analysis and generation of conclusions.

R=In the case of the state of Veracruz, diabetes occurs as the 2nd. most prevalent disease, and cardiovascular diseases are the second cause of death (27-28), and the city of Veracruz, where the data were collected, was the city with more Covid-19 reported cases.

5. The variables that are going to be used to analyze the gender perspective are not described, there is only sex. It is not clear if the PCWLS scale was validated in the sample studied.

R= The PCWLS scale was validated by by Góngora-Coronado and Vázquez-Velázquez.

6. Among the results, they affirm that differences were found in risk factors for contracting covid, it must be taken into account that this type of study does not allow us to rigorously identify these differences in risk factors, what is proposed is the analysis of the comorbidities of the people positive for Covid-19.

R=According to the purpose of the study, we analyzed which aspects of positive coping are linked to the stress response, and with the presence/absence of important metabolic diseases in Mexico and in the context of the COVID-19 pandemic, from a gender perspective.

7. It remains to be clarified whether it was possible to identify the analysis of the aspects that determine health and well-being from a gender perspective in the methods and present it in the conclusions in people with confirmed Covid-19.

R=According to the purpose of the study, we analyzed which aspects of positive coping are linked to the stress response, and with the presence/absence of important metabolic diseases in Mexico and in the context of the COVID-19 pandemic, from a gender perspective. Sadly we do not have access to the data for the COVID confirmed data.

The selection bias that occurs when selecting people who consult a health service for symptoms of Covid-19 must be declared, since they may have different conditions or characteristics from those who do not consult.

R= The data was collected from those people who requested a diagnostic test for COVID-19. Therefore, the possible deviation could be in the fact that only those who arrived were sampled and not those who, having symptoms that suggested COVID.19, did not request the diagnosis.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

R= The format was checked up

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

R=The procedures has been described in the Methods section.

Following all sanitary measures indicated during the COVID-19 pandemic, participants were verbally informed about the objectives of the protocol; once they agreed to participate, a Google Forms link via What’s App, was sent to them, to obtain informed consent via on line, and answer the general data questionnaire and the psychological tests. Personal data was processed in accordance with the policy of the Institute for Transparency, Access to Public Information, Protection of Personal Data. Once registered, a Google Forms link was sent through WhatsApp to answer a file with general data and psychological tests. This work was carried out following the Code of Ethics of the Declaration of Helsinki and approved by the Committee of Ethical Research of the CESS.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This research has been funded by Dirección General de Investigaciones of Universidad Santiago de Cali under call No. 01-2022."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"This research has been funded by Dirección General de Investigaciones of Universidad Santiago de Cali under call No. 01-2022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

R= The text has been modified and removed.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

R=The repository files have been included.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

All were incorporated according to the guide for the author.

S1_fig

S2_fig

S3_fig

S4_fig

S1_table

S2_table

S3_table

Reviewers' comments:

Reviewer #1: I recommend the authors to mention the following findings related to gender, COVID-19 and mental health in the Introduction and discussion, I will review this paper again.

R= We have reviewed the articles proposed by the reviewer and written brief comments that summarize their vision, as follows:

At the same time, during the COVID 19 pandemic, numerous reports were made that indicated increased levels of anxiety, stress, and a greater psychological impact on women.

Attachments
Attachment
Submitted filename: Response to the reviewers.docx
Decision Letter - Diana Marcela Walteros Acero, Editor

STRESS SYMPTOMS AND POSITIVE COPING DURING CORONAVIRUS DISEASE 2019: THE NEED TO LOOK AT HEALTH FROM A GENDER PERSPECTIVE

PONE-D-22-34111R1

Dear Dr. Romo-González,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Diana Marcela Walteros Acero, M.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The comments were reviewed by the authors and resolved appropriately, the comments of the authors as well as the editor were taken into account.

The manuscript presents original research on aspects of mental health in the Covid-19 pandemic, considering it a topic of interest, it contributes to the generation of new knowledge. The authors declare the source of the resources for the research and the manuscript as well as the conflicts of interest"

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I recommend publication for the paper "STRESS SYMPTOMS AND POSITIVE COPING DURING CORONAVIRUS DISEASE

2019: THE NEED TO LOOK AT HEALTH FROM A GENDER PERSPECTIVE"

:"

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Formally Accepted
Acceptance Letter - Diana Marcela Walteros Acero, Editor

PONE-D-22-34111R1

Stress symptoms and positive coping during coronavirus disease 2019: the need to look at health from a gender perspective

Dear Dr. Romo-González:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Diana Marcela Walteros Acero

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .